CYTONOME/ST LLC

In News

Cytonome Congratulates Sumitomo Pharma on Regulatory Approval for Regenerative Medicine Therapy for Parkinson’s disease - BioInformant

BioInformant - Mar 11, 2026

Sumitomo Dainippon Pharma Co. Ltd. Chooses Cytonome's GigaSort® Cell Sorting Technology for Cell Bioprocessing - newswire.com

newswire.com - Apr 03, 2018

Cytonome cell sorter aids in Parkinson’s treatment - BioInformant

BioInformant - Apr 06, 2021

Think Before You Draft: Patent Prosecution Has Consequences For Patent Litigation - Hunton Andrews Kurth LLP

Hunton Andrews Kurth LLP - Dec 05, 2023

Patent Filings Roundup: IP Edge Sues 26; Quirky IP Files for Creator; Spell Check Targeted - IPWatchdog.com

IPWatchdog.com - Sep 02, 2020

“A”/“An” Means “One or More,” Said the Federal Circuit…Again - Lexology

Lexology - Oct 25, 2023

Brushed Aside? Dafni Tries to Keep its PTAB Win against Ontel - Patently-O

Patently-O - Dec 06, 2023

ASP Isotopes Appoints Heather Kiessling as Chief Financial Officer - citybiz

citybiz - Jun 13, 2024

Cytonome Licenses GigaSort Technology for Cell Therapy Manufacture - BioInformant

BioInformant - Jan 26, 2017

Patent Filings Roundup: Lighthouse Campaign Snuffed Out, At Liberty to Sue, Express Train Rolls On - IPWatchdog.com

IPWatchdog.com - Sep 09, 2020

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment